In Charcot-Marie-Tooth disease (CMT), a hereditary peripheral neuropathy, mutant glycyl-tRNA synthetase (GARS) loses its binding capacity to SIRT2, leading to reduced α-tubulin acetylation levels. Here, GARS1 is linked to peripheral neuropathy.